“…Methicillin-susceptible ST772 S. aureus was originally reported in Bangladesh, but this was quickly followed by reports of ST772-MRSA-V in India and Malaysia and subsequently in England, Italy, Australia, Germany, Hong Kong, and Abu Dhabi (1,13,15,24,26,34). Many patients identified with ST772-MRSA-V outside India had familial links in, or travel history to or from, India, resulting in the ST772-MRSA-V clone being dubbed the Bengal Bay clone (15,24,26). In addition, ST772-MRSA-V is increasingly prevalent in India, where it has spread into hospitals and, along with ST22-MRSA-IV, has displaced the previously predominant nosocomial ST239-MRSA-III clone (13).…”